Terms: = Lymphoma AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Clinical Outcome
10 results:
1. Dysregulated expression of SKP2 and its role in hematological malignancies.
Kulinski M; Achkar IW; Haris M; Dermime S; Mohammad RM; Uddin S
Leuk Lymphoma; 2018 May; 59(5):1051-1063. PubMed ID: 28797197
[TBL] [Abstract] [Full Text] [Related]
2. Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma.
Dong LH; Cheng S; Zheng Z; Wang L; Shen Y; Shen ZX; Chen SJ; Zhao WL
J Hematol Oncol; 2013 Jul; 6():53. PubMed ID: 23866964
[TBL] [Abstract] [Full Text] [Related]
3. Overexpression of phosphorylated p27 kip1 at threonine 187 may predict outcome in aggressive B-cell lymphomas.
Sirinian C; Symeonidis A; Giannakoulas N; Zolota V; Melachrinou M
Leuk Lymphoma; 2011 May; 52(5):814-22. PubMed ID: 21338280
[TBL] [Abstract] [Full Text] [Related]
4. VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27(kip1) via paracrine mechanisms.
Roorda BD; Ter Elst A; Scherpen FJ; Meeuwsen-de Boer TG; Kamps WA; de Bont ES
Eur J Cancer; 2010 Mar; 46(5):974-82. PubMed ID: 20064707
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients.
Liu YH; Xu FP; Zhuang HG; Lai KC; Xie D; Luo DL; Li L; Luo XL; Xu J; Zhang MH; Zhang F; Li HM
Hum Pathol; 2008 Jun; 39(6):875-84. PubMed ID: 18440593
[TBL] [Abstract] [Full Text] [Related]
6. Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo.
Zhang W; Bergamaschi D; Jin B; Lu X
Blood; 2005 May; 105(9):3691-8. PubMed ID: 15665120
[TBL] [Abstract] [Full Text] [Related]
7. Spontaneous apoptosis of Reed-Sternberg and Hodgkin cells; clinical and pathological implications in patients with Hodgkin's disease.
Smolewski P; Niewiadomska H; Los E; Robak T
Int J Oncol; 2000 Sep; 17(3):603-9. PubMed ID: 10938405
[TBL] [Abstract] [Full Text] [Related]
8. Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.
Møller MB; Kania PW; Ino Y; Gerdes AM; Nielsen O; Louis DN; Skjødt K; Pedersen NT
Leukemia; 2000 May; 14(5):898-904. PubMed ID: 10803523
[TBL] [Abstract] [Full Text] [Related]
9. p27kip1 is abnormally expressed in Diffuse Large B-cell lymphomas and is associated with an adverse clinical outcome.
Sáez A; Sánchez E; Sánchez-Beato M; Cruz MA; Chacón I; Muñoz E; Camacho FI; Martínez-Montero JC; Mollejo M; García JF; Piris MA
Br J Cancer; 1999 Jul; 80(9):1427-34. PubMed ID: 10424746
[TBL] [Abstract] [Full Text] [Related]
10. Anomalous high p27/kip1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/kip1-cyclin D3 colocalization in tumor cells.
Sánchez-Beato M; Camacho FI; Martínez-Montero JC; Sáez AI; Villuendas R; Sánchez-Verde L; García JF; Piris MA
Blood; 1999 Jul; 94(2):765-72. PubMed ID: 10397744
[TBL] [Abstract] [Full Text] [Related]
